BridgeBio Pharma to Host Virtual R&D Day on October 12, 2021

PALO ALTO, Calif.: PALO ALTO, Calif., Oct. 6, 2021 /PRNewswire/ -- BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company that focuses on genetic diseases and cancers, today announced that it will host its second R&D Day on Tuesday, October 12, 2021, at 8:30 a.m. ET. BridgeBio founder and CEO...

Click to view original post